Market revenue in 2023 | USD 49.4 million |
Market revenue in 2030 | USD 98.8 million |
Growth rate | 10.4% (CAGR from 2023 to 2030) |
Largest segment | Tavr (transcatheter aortic valve replacement) |
Fastest growing segment | LAAC (Left Atrial Appendage Closure) |
Historical data | 2018 - 2022 |
Base year | 2023 |
Forecast period | 2024 - 2030 |
Quantitative units | Revenue in USD million |
Market segmentation | SAVR (Surgical Aortic Valve Replacement), TAVR (Transcatheter Aortic Valve Replacement), Mitral Repair (Annuloplasty), LAAC (Left Atrial Appendage Closure) |
Key market players worldwide | Boston Scientific Corp, Medtronic PLC, Edwards Lifesciences Corp, Abbott Laboratories, St. Jude Medical, LivaNova PLC, Stryker Corp, Lepu Medical, Biomerics, CardioKinetix |
No credit card required*
Name | Profile | # Employees | HQ | Website |
---|
The databook is designed to serve as a comprehensive guide to navigating this sector. The databook focuses on market statistics denoted in the form of revenue and y-o-y growth and CAGR across the globe and regions. A detailed competitive and opportunity analyses related to structural heart devices market will help companies and investors design strategic landscapes.
Tavr (transcatheter aortic valve replacement) was the largest segment with a revenue share of 52.23% in 2023. Horizon Databook has segmented the Saudi Arabia structural heart devices market based on savr (surgical aortic valve replacement), tavr (transcatheter aortic valve replacement), mitral repair (annuloplasty), laac (left atrial appendage closure) covering the revenue growth of each sub-segment from 2018 to 2030.
In Saudi Arabia, the cardiovascular devices market, encompassing structural heart devices, is experiencing remarkable growth and is poised for further expansion in the foreseeable future. The healthcare sector in the country has undergone significant transformations, resulting in a surge in cardiac surgeries and a heightened demand for cardiovascular devices like cardiac catheters.
This growth is primarily fueled by factors such as the escalating prevalence of CVDs, rapid technological advancements, and an increasing need for cardiac procedures due to enhanced hospital services and heightened awareness regarding heart conditions.
The momentum of this growth is bolstered by impactful initiatives such as the Arab Health 2022 exhibition, where leading medical technology companies like Medtronic unveiled cutting-edge products like the Hugo Robotic-Assisted Surgery (RAS) system.
Horizon Databook provides a detailed overview of country-level data and insights on the Saudi Arabia structural heart devices market , including forecasts for subscribers. This country databook contains high-level insights into Saudi Arabia structural heart devices market from 2018 to 2030, including revenue numbers, major trends, and company profiles.
Sign up and get instant basic access to databook, upgrade
when ready, or enjoy our
free plan indefinitely.
Included in Horizon account